Loading…
Lobbying Spend
—
Filings
17
Firms Hired
1
Active Period
2021–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Financial Services and General Government Appropriations Act, 2024
2024 · fourth_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.2309
SUPPORT for Patients and Communities Reauthorization Act
2024 · fourth_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.3393
Financial Services and General Government Appropriations Act, 2024
2024 · third_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.2309
SUPPORT for Patients and Communities Reauthorization Act
2024 · third_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.3393
Financial Services and General Government Appropriations Act, 2024
2024 · second_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.2309
SUPPORT for Patients and Communities Reauthorization Act
2024 · second_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.3393
Financial Services and General Government Appropriations Act, 2024
2024 · first_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.2309
SUPPORT for Patients and Communities Reauthorization Act
2024 · first_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.3393
Financial Services and General Government Appropriations Act, 2024
2023 · fourth_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.2309
SUPPORT for Patients and Communities Reauthorization Act
2023 · fourth_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
Client expense: — · Firm income: $60,000
Matched citations: S.3393
Mainstreaming Addiction Treatment Act of 2021
2022 · fourth_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 1384
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 2067
Restoring Hope for Mental Health and Well-Being Act of 2022
2022 · fourth_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 7666
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 955
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: S.285
Mainstreaming Addiction Treatment Act of 2021
2022 · third_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 1384
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 2067
Restoring Hope for Mental Health and Well-Being Act of 2022
2022 · third_quarter · Firm: PUTALASTRATEGIES
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 7666
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 955
Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: S.285
Mainstreaming Addiction Treatment Act of 2021
2022 · second_quarter · Firm: PUTALASTRATEGIES
HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. S.Con.Res.14-Budget Resolution (issues related to pharmaceutical treatments for opioid use disorders). HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 1384
HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. S.Con.Res.14-Budget Resolution (issues related to pharmaceutical treatments for opioid use disorders). HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 2067
Restoring Hope for Mental Health and Well-Being Act of 2022
2022 · second_quarter · Firm: PUTALASTRATEGIES
HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. S.Con.Res.14-Budget Resolution (issues related to pharmaceutical treatments for opioid use disorders). HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 7666
HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. S.Con.Res.14-Budget Resolution (issues related to pharmaceutical treatments for opioid use disorders). HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: HR 955
HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. S.Con.Res.14-Budget Resolution (issues related to pharmaceutical treatments for opioid use disorders). HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.
Client expense: — · Firm income: $60,000
Matched citations: S.285
Source: Senate LDA